FFFarah Farzaneh

Farah Farzaneh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Farah Farzaneh has a total of 166 co-authors. Here are the top co-authors by number of shared publications:

  • Maliheh Arab

    Department of Obstetrics and Gynecology, School of Medicine, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    7 shared publications
  • Maryam Sadat Hosseini

    Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Nahid Khodakarami

    Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Kamyab Alizadeh

    4 shared publications
  • Sanaz Hariri Tabrizi

    Department of Medical Radiation Engineering, Shahid Beheshti University, Tehran, Iran

    4 shared publications
  • Loretta Brabin

    Academic Unit of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, University of Manchester, School of Cancer and Enabling Sciences, Manchester M13 OJH, UK

    3 shared publications

Latest Publications

  • Open Access

    In Vitro Study of Curcumin Release from MOF Nanocarrier Based on Metal-Organic Framework Structure and Its Effect on Cancer Cells: A Laboratory Study

    by Mostafa Bashiri Barazandeh, Hadi Tabesh, Farah Farzaneh, Ali Golkar

    Background and Objectives: Ovarian cancer is one of the most aggressive malignancies in women, characterized by limited treatment options and drug resistance. Drug nanocarriers can significantly improve the treatment process by enhancing efficacy and reducing toxicity. This study aimed to synthesize and evaluate CUR@ZIF-8 nanoparticles to increase the stability, bioavailability, ...

  • Open Access

    Menstrual Cycle Disturbances after COVID-19 Vaccination: A Cross-Sectional Study

    by Farima Rahimi Mansour, Amirreza Keyvanfar, Hanieh Najafiarab, Shaghayegh Hooshmand Chayijan, Farah Farzaneh, Golnoush Mortezaei

    Background: Following COVID-19 vaccination, some women suffered from menstrual cycle disturbances. This study aimed to investigate menstrual cycle disturbances after COVID-19 vaccination in women of reproductive age. Materials and Methods: This cross-sectional study was performed on 407 vaccinated women in the vaccination center of Imam Hossein Hospital (Tehran, Iran) between October 2021 and October 2022. They were interviewed based on a research-made checklist which consisted of two areas of questions about the baseline characteristics of participants and menstrual cycle characteristics to explore menstrual characteristics following COVID-19 vaccination. Results: The prevalence of menstrual disturbances was higher after the third dose (38.3%) compared with the second (27.9%) and first (17.7%) doses (P<0.001). After the first dose, a history of polycystic ovarian syndrome [PCOS, odds ratio (OR)=7.35, 95% confidential interval (CI)= (3.64-14.82), P<0.001] and menstrual disturbances with unknown etiology [OR=15.23, 95% CI=(6.30-36.80), P<0.001] could predict menstrual disturbances. After the second dose, a history of menstrual disturbances with unknown etiology [OR=3.83, 95% CI=(1.47-9.94), P=0.006] and menstrual disturbances after the first dose [OR=201.96, 95% CI= (40.99-994.90), P<0.001] were predictors of menstrual disturbances. After the third dose, a history of menstrual disturbances with unknown etiology [OR=3.09, 95% CI= (1.00-9.52), P=0.048], menstrual disturbances after the first [OR=9.82, 95% CI=(1.38-69.69), P=0.022] and second [OR=7.83, 95% CI=(1.46-41.92), P=0.016] doses could predict menstrual disturbances. Conclusion: We detected that many women experienced various menstrual disturbances after vaccination against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Furthermore, a history of menstrual abnormalities (before COVID-19 vaccination and following the previous doses of these vaccines) was associated with developing menstrual disturbances.

  • Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year Survival Analysis Study

    by Farah Farzaneh, Azadeh Jafari Ashtiani, Mehrdad Bohlooli, Maryam Sadat Hosseini

    Background: During the last few years, Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has entered the national comprehensive cancer network guidelines as a new protocol for improving patients’ outcomes. However, there is no consensus on its long-term efficiency, and it still is under debate. Objectives: This study aims to evaluate the effectiveness of Cytoreductive Surgery Plus hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer in Iran. Method: Thirty patients with Stage IIIc and IV advanced ovarian cancer underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy at Jam Hospital with a fixed surgical team in Tehran, Iran, from 2019 to 2021. Fourteen patients were new cases, and sixteen of them were recurrent cases. At the end of cytoreductive surgery, by using a hyperthermic intraperitoneal chemotherapy device, Cisplatin was circulated in the peritoneal cavity for 90 minutes at a dose of 80-100 mg/ m2 at 43°C. Results: Among 30 patients with 54.97±10.74 years of mean age, the mean overall survival was 564.967 days, and 2-year survival rates were 66.7%. According to Fisher's exact test, there was a statistically significant relationship between disease-free after surgery and mortality rate (p=0.00). However, there was no statistically significant relationship between recurrence after surgery and mortality rate (p=0.093). Conclusion: Based on these findings, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy had a survival rate of 66.7% within two years in advanced ovarian cancer patients. However, to achieve better results, careful selection of patients and complete cytoreductive surgery should be performed.


  • Open Access

    Evaluation of anal cytology and human papillomavirus infection in high-risk women: a cross-sectional study

    by Tahereh Ashrafganjoei, Maryam Sadat Hosseini, Zanbagh Pirastehfar, Farah Farzaneh, Maliheh Arab, Noushin Ashfar Moghaddam, Abdolreza Javadi, Ali Yaghobi Joybari

    BACKGROUND Anal cancer incidence has been on the rise over the past few decades. This study aimed to assess anal Papanicolaou (Pap) smear changes in women with high risk for dysplasia and human papillomavirus (HPV) infection. METHODS This cross-sectional study was conducted on 121 patients referred to the Gynecology Oncology Clinic of Imam Hossein Medical Center between 2020 and 2021 in Tehran, Iran, who had cervical and vulvar dysplasia, cervical HPV infection, and abnormal cervical cytology results and were over 21 years old. Data analysis was performed using SPSS software version 21 (IBM Corp., USA) at a significance level of 0.05. RESULTS 121 women, with a mean age of 39.69 years, were included in this study. Overall, 23.1% of women had positive anal HPV results, and 35.5% were over 40 years old. Younger age was associated with an increased risk of anal HPV (p = 0.045). 33.9% of women were single and had a higher risk of anal HPV. Multiple sexual partnerships and anal sex were the significant risk factors for anal cancer (p<0.001). Women with positive anal HPV results had significantly more genital warts (p<0.001). No significant difference was observed in smoking, educational level, and cervical Pap smear results between women with negative and positive rectal HPV results. CONCLUSIONS Younger age at diagnosis, being single, having multiple sexual partnerships, having anal sex, and having genital warts were associated with anal HPV infection in women. Abnormal anal cytology was only associated with being single and having multiple sexual partners.


  • Open Access

    Combination of surgery and laser for the treatment of extensive VIN3 and vulval condyloma: A case report

    by Farah Farzaneh, Leila Khalili, Nasser Rakhshani, Faramarz Beyraghdar, Afsaneh Hosseini

    Vulval intraepithelial neoplastic lesions (VINs) are rare lesions that appear with limited signs of pre-malignancy restricted to the vulvar epithelium. One of the principal causes of VINs is the human papillomavirus (HPV) infection, especially in people with weakened immune systems and young women. A 35-year-old woman presented with VIN3 who had severe immunosuppression and was under corticosteroid treatment. Her lesions were treated with a laser and surgical excision. Pathological findings indicated full thickness dysplasia and HPV infection. Follow-up after 5 years showed complete recovery and no recurrence, with a restoration of the vulva esthetics. Due to the increasing prevalence of VIN malignancy in young women and the importance of maintaining normal anatomy and function of the genitalia, a combination of surgery and laser can be used instead of extensive surgery only.

  • Open Access

    COVID-19 Infection in Iranian Pregnant Women: A Case Series of 25 Patients

    by Maryamsadat Hosseini, Farah Farzaneh, Mahsa Mirhadi, Seyed Ali Akbar Mahdavi Anari, Ladan Ajori, Saghar Salehpour, Tayebeh Jahed Bozorgan, Parichehr Pooransari, Shideh Ariana, Minoo Yaghmaei, et al.

    Background & Objective: The COVID-19 infection remains a major pandemic threatening global health. Studies revealed that pregnant women are more prone to develop severe illness, with an increased risk of morbidity and mortality. So the objective of this study is to report the clinical presentation and perinatal outcomes after COVID-19 infection during ...


  • Open Access

    Comparison of the International Association of Diabetes in Pregnancy Study Group Criteria with the Old American Diabetes Association Criteria for Diagnosis of Gestational Diabetes Mellitus

    by Mahtab Niroomand, Jamileh Afsar, Farhad Hosseinpanah, Maryam Afrakhteh, Farah Farzaneh, Sara Serahati

    This study aimed to assess the frequency of gestational diabetes mellitus (GDM) based on two sets of criteria, namely the old criteria suggested in 2009 by ...


  • Open Access

    Evaluation of Neutrophil–Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence

    by Farah Farzaneh, Nafiseh Faghih, Maryam Sadat Hosseini, Maliheh Arab, Tahereh Ashrafganjoei, Atyeh Bahman

    Background: Immune system status is a factor related to cervical intraepithelial neoplasia (CIN) recurrence.neutrophil-lymphocyte ratio (NLR) is a useful factor in assessing the immune status. The aim of this study was toevaluate the prognostic value of NLR factor for CIN recurrence in patient who underwent excisional procedure and itsrelationship with recurrence free survival (RFS). Methods: In this historical cohort study, a population of 307 patientswith CIN (confirmed by excisional pathology) from 2009 to 2017 were selected. NLR and hematologic factors weremeasured before surgery and the follow-up records of these patient were analyzed. The recurrence rate and RFS wereassessed during the follow-up phase. Results: The NLR cut-off point of 1.9 was determined using the Youden Index.NLRUnivariate analysis showed that higher NLR values (P<0.001), absolute neutrophilic counts (ANC) (P<0.001) andplatelet lymphocytic ratios (PLR) (P=0.002) were significantly associated with reduction in RFS. The results of Coxregression showed that removing more tissue during excision (HR = 0.325; 95% CI (0.936-0.136) significantly reducedthe hazard of recurrence, higher NLR (HR = 4.55; 95% CI) (1.97-10.51) and white blood cell (WBC) count levels (HR=1.27; 95% CI, 1.04-1.55), significantly decreased RFS, but PLR and ANC associated with RFS were not confirmedby Cox regression. Conclusion: NLR and total WBC count might be prognostic factors involved in the prediction ofrecurrence and RFS in CIN patient underwent excisional procedure. To confirm these results, more prospective studieswith larger sample sizes are needed.


  • Open Access

    The Trend of Abnormal Cervical Cytology Among Iranian Women During Recent Years from 2013 to 2016

    by Farah Farzaneh, Farzaneh Jamdar, Sarang Younesi, Mehdi Taheri Amin, Pourandokht Saadati, Fariba Navidpour, Payam Balvayeh, Robabeh Ghodssi-Ghasemabadi, Maryam Sadat Hosseini, Tehran Technical Manager Of Nilou Medical Laboratory, et al.

    Background: Cervical cancer is one of the common cancers in developing countries, which has a high rate of mortality. This study aimed to evaluate the prevalence of abnormal cervical cytology among Iranian women. Methods: In this cross-sectional study, cervical cytological results of 137,484 Iranian women, who were screened for cervical cancer ...